Vaccine Central

The latest vaccine stories




The latest coronavirus stories







Pfizer aims for full FDA approval of vaccine

Drugmaker Pfizer has begun the process to earn full U.S. regulatory approval for its COVID-19 vaccine for people aged 16 and older, and also applied to the FDA to expand the current emergency authorization to people ages 12 to 15.